Ritschel W A, Elconin H, Alcorn G J, Denson D D
Biopharm Drug Dispos. 1985 Jul-Sep;6(3):281-90. doi: 10.1002/bdd.2510060303.
Lidocaine shows pronounced first-pass metabolism upon peroral administration in man (about 30 per cent peroral bioavailability). Since the rectal bioavailability is about 65 per cent in man it is assumed that some drug is directly absorbed into systemic circulation by-passing the liver. In rats peroral bioavailability is about 8 per cent whereas rectal bioavailability is about 100 per cent. This indicates that the rat is not a suitable model to study rectal lidocaine dosage forms. The purpose of this study was to investigate lidocaine disposition and bioavailability in rabbits after peroral and rectal administration. The peroral bioavailability in rabbits was found to be about 6 per cent and the rectal bioavailability is about 33 per cent. The results indicate that the rabbit is a suitable model for the study of systemic absorption of rectal lidocaine dosage forms.
利多卡因在人体口服给药后显示出明显的首过代谢(口服生物利用度约为30%)。由于在人体中直肠生物利用度约为65%,因此推测部分药物绕过肝脏直接吸收进入体循环。在大鼠中,口服生物利用度约为8%,而直肠生物利用度约为100%。这表明大鼠不是研究直肠利多卡因剂型的合适模型。本研究的目的是调查家兔口服和直肠给药后利多卡因的处置和生物利用度。发现家兔的口服生物利用度约为6%,直肠生物利用度约为33%。结果表明,家兔是研究直肠利多卡因剂型全身吸收的合适模型。